Emergency Medicine Reports - December 25, 2005

Target Audience:

This continuing medical education activity is intended for emergency physicians.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Authors
Sharon G. Humiston, MD, MPH
Associate Professor of Emergency Medicine
Department of Emergency Medicine
University of Rochester, NY

Anne F. Brayer, MD
Department of Emergency Medicine
University of Rochester, NY

Peer Reviewers
Robert W. Schafermeyer, MD, FACEP, FAAP, FIFEM
Associate Chair
Department of Emergency Medicine
Carolinas Medical Center;
Adjunct Professor of Emergency Medicine and Pediatrics
University of North Carolina School of Medicine
Charlotte

Ann Dietrich, MD, FAAP, FACEP
Associate Clinical Professor
Ohio State University
Attending Physician
Columbus Children?s Hospital
Associate Pediatric Medical Director
MedFlight
Columbus, OH

Editor-In-Chief
Gideon Bosker, MD
Special Clinical Projects and Medical
Education Resources
Assistant Clinical Professor
Section of Emergency Services
Yale University School of Medicine

CME Question Reviewer
Roger Farel, MD
Retired
Newport Beach, CA

Subjects:

  • Meningococcal Disease Part II: Diagnostic Studies, Differential Diagnosis, and Management

Objectives:

  • quickly recognize or increase index of suspicion for specific conditions
  • understand the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • apply state-of-the-art diagnostic and therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed
  • understand the differential diagnosis of the entity discussed
  • understand both likely and rare complications that may occur

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Sharon G. Humiston, MD, MPH (author) has conducted research for the CDC National Immunization Program. She has served on advisory boards for GlaxoSmithKline (Pediarix and Boostrix) and Merck Vaccine Division (rotavirus vaccine). She also has given CME talks or papers sponsored by state health departments, continuing medical education companies, NAPNAP, Medical Society of the State of New York, National Foundation for Infectious Diseases, Sanofi Pasteur, GlaxoSmithKline, and Merck Vaccine Division.

Roger Farel, MD (CME question reviewer) owns stock in Johnson and Johnson.

Anne F. Brayer, MD (author), Robert W. Schafermeyer, MD, FACEP, FAAP, FIFEM (peer reviewer), and Ann Dietrich, MD, FAAP, FACEP (peer reviewer) report no relationships with companies related to the field of study covered by this CME activity.

Gideon Bosker, MD, FACEP (editor) has been compensated for speaking engagements and/or editorial services related to production of peer-reviewed Clinical Consensus Reports under the auspices of unrestricted educational grants for Pfizer, Sanofi-Aventis, Bristol-Myers Squibb, Roche Pharmaceuticals, Bayer, Novartis, Forest Pharmaceuticals, and Schering Plough Corporation.

Dr. Bosker also acknowledges that he has received royalties, commissions, and other compensation relating to the sale of textbooks, reprints of articles, and/or other electronic or print materials to the following pharmaceutical companies: Pfizer, Sanofi-Aventis, Bayer, Roche, Forest Laboratories, and Novartis. He is a minor stockholder in Pfizer. Any other stock ownership which he may have in other pharmaceutical companies is managed in blinded fashion by an independent consultant without Dr. Bosker’s input or consultation.

Copyright 2006 AHC Media. All rights reserved.